IOVacc is a biotechnology company developing new drugs in clinical stages.
We develop breakthrough therapies with the latest generation of miRNAs. Our aim is to find the pathways to cure diseases with unmet medical needs. The purpose of our drugs is to treat rare and complex diseases using the latest discovery of the transcriptome.
On the other hand, we are working on drugs that could change the lives of patients who have no treatment options.
The IOVacc technological approach is unique and offers efficiency and breakthrough results.
IOVacc positions with highly specialized expertise in the metabolic disorders and immuno-oncology. Our mission is to find new science and efficient channels for improved health solutions.